Résumé des résultats (Abstract)
(Anglais)
|
CAPTAIM provides an advanced liquid biopsy platform, leveraging high-resolution blood analysis to guide cancer vaccine design. It enables minimally invasive, highly specific tumor profiling ? particularly for hard-to-access tumors ? boosting reach and treatment efficacy of precision-guided vaccines.
|
